Osteopathic treatment for gastro-oesophageal reflux disease
Osteopathic Manipulative Treatment for Patients Affected by Symptoms Related to Gastro-oesophageal Reflux Disease
This study tests if osteopathic treatment can help people with gastro-oesophageal reflux disease feel better by reducing symptoms like heartburn and regurgitation.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Sex | All |
| Sponsor | Studio Osteopatico Busto Arsizio Academic / other |
| Locations | 1 site (Saronno, Varese) |
| Trial ID | NCT06317675 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of osteopathic manipulative treatment (OMT) on patients suffering from gastro-oesophageal reflux disease (GERD). Participants will receive OMT to address symptoms such as retrosternal burning and regurgitation, with a focus on those who have been experiencing these symptoms for over three months. The study aims to determine the efficacy of OMT as a non-pharmacological intervention for GERD management.
Who should consider this trial
Good fit: Ideal candidates are individuals experiencing GERD symptoms for more than three months, including those on proton pump inhibitors.
Not a fit: Patients with neoplastic pathologies, those who have undergone GERD surgery, or individuals with active gastric ulcers will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive alternative for managing GERD symptoms.
How similar studies have performed: While there is limited data on the effectiveness of OMT for GERD, similar manual therapies have shown promise in treating other gastrointestinal conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Retrosternal burning sensation and/or regurgitation * Diagnosis of reflux with any methodology * Duration of symptoms for more than 3 months * Taking short or long-term proton pump inhibitors (as needed, treatment start date and expected end date, mg, drug name) * With or without esophagitis * With or without hiatal hernia * With or without helicobacter pylori * GERDQ questionnaire \> 8 points Exclusion Criteria: * neoplastic pathologies * patients who have undergone surgery for GERD * systemic pathologies (rheumatic, infectious conditions, feverish state, vascular alterations, endocrine diseases including diabetes, metabolic and neoplastic syndromes), * patients already undergoing manipulative therapy for reflux * patients with active gastric ulcers * congenital or acquired immune diseases * allergic state of any kind * pregnancy * use of intrauterine device * patients undergoing corticosteroid therapy * patients already subjected to manual/respiratory therapy in the last 3 months
Where this trial is running
Saronno, Varese
- Ctfo — Saronno, Varese, Italy (Recruiting)
Study contacts
- Study coordinator: Carolina Lavazza
- Email: carolina.lavazza@docenti.aimoedu.it
- Phone: +39 02 96701013
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.